Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Perronne

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|August 2, 2003
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)Eric Rosenthal, Marilyne Poirée, Christian Pradier, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature reviewLouis Bernard, Anne Lübbeke, Richard Stern, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
AIDS (London, England)|July 11, 2008
Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patientsFabrice Carrat, Pierre Bedossa, Françoise Lunel-Fabiani, et al.
AIDS (London, England)|June 27, 2008
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirinFirouzé Bani-Sadr, Isabelle Goderel, Nathanael Lapidus, et al.
Journal of Hepatology|August 30, 2008
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapyLionel Piroth, Fabrice Carrat, Sylvie Larrat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatmentFirouzé Bani-Sadr, Fabrice Carrat, Eric Rosenthal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trialJérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 24, 2018
Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trialJérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 25, 2020
Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>Jérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|August 2, 2003
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)Eric Rosenthal, Marilyne Poirée, Christian Pradier, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature reviewLouis Bernard, Anne Lübbeke, Richard Stern, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary TuberculosisPiero L Olliaro, Corinne Merle, Thuli Mthiyane, et al.
AIDS (London, England)|July 11, 2008
Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patientsFabrice Carrat, Pierre Bedossa, Françoise Lunel-Fabiani, et al.
AIDS (London, England)|June 27, 2008
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirinFirouzé Bani-Sadr, Isabelle Goderel, Nathanael Lapidus, et al.
Journal of Hepatology|August 30, 2008
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapyLionel Piroth, Fabrice Carrat, Sylvie Larrat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatmentFirouzé Bani-Sadr, Fabrice Carrat, Eric Rosenthal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trialJérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 24, 2018
Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trialJérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 25, 2020
Retraction notice to <"Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial"> <[PHYTOMEDICINE 57C (2019) 49-56]>Jérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Pageof 10